News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Continue Reading Previous Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial ResistanceNext XORTX Announces Participation at Upcoming Investor Conferences Related Stories News Silver Hammer and Stroud Resources Announce Updated Mineral Resource Estimate for the Santo Domingo Silver-Gold Project, Mexico News Acceleware Ltd. Reports Second Quarter 2026 Financial and Operating Results News Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update News Theralase(R) Releases Q2 2026 Financial Statements News Ticket Fairy Launches the World’s First Event Ticketing Command Line Built for AI Agents News Mesmerise Launches Call-to-Sale Attribution System After Audit Finds Most Conversions Invisible to Standard Tracking
